The clinical implications of progenitor cells in multiple myeloma
Gareth Morgan et al.
The importance of the microenvironment in multiple myeloma
Preliminary data on managing adults with ALL without hematopoietic stem cell transplantation
Results of Phase III POLLUX trial on daratumumab in multiple myeloma
The first in-human Phase I study of a BET inhibitor for the treatment of NHL